Apogee Therapeutics (APGE) Earnings Analysis
Apogee Therapeutics (APGE) next reports earnings on 2026-08-10, consensus EPS -1.1 USD. Last quarter (2026-05-11) it beat with EPS -1.06 USD vs -1.07 USD est (+0.9%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -30.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does APGE next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -1.1 USD |
| Revenue estimate | 0.01B |
APGE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -1.06 USD | -1.07 USD | +0.9% | Beat |
| 2026-03-02 | -1.03 USD | -1.05 USD | +1.9% | Beat |
| 2025-11-10 | -1.11 USD | -1.12 USD | +0.9% | Beat |
| 2025-08-11 | -1.13 USD | -1.03 USD | -9.7% | Miss |
| 2025-05-12 | -0.95 USD | -1.19 USD | +20.2% | Beat |
| 2025-03-03 | -1.19 USD | -0.94 USD | -26.6% | Miss |
| 2024-08-12 | -0.6 USD | -0.64 USD | +6.3% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
APGE valuation and analyst view
| Trailing P/E | -30.97 |
|---|---|
| Trailing EPS | -3.94174 USD |
| Price / book | 7.44 |
| Dividend yield | 0.00% |
| Market cap | 8.30B |
| Analyst consensus | Hold (3 buy / 11 hold / 0 sell) |
| Avg price target | 122.93 USD |
Related research pages
Frequently asked questions
When is Apogee Therapeutics (APGE)'s next earnings date?
Apogee Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -1.1 USD and revenue estimate of 0.01B.
Did APGE beat earnings last quarter?
In its 2026-05-11 report, APGE posted EPS of -1.06 USD versus a -1.07 USD estimate — a beat of 0.9%.
What is APGE's earnings track record?
Over the last 7 reported quarters with consensus data, APGE beat estimates 5 times (71%).
What is APGE's current P/E ratio and EPS?
APGE trades at a trailing P/E of -30.97 on trailing EPS of -3.941741826596689 USD.
What do analysts rate APGE?
Analyst consensus is "Hold" across 14 ratings (0 strong buy, 3 buy, 11 hold, 0 sell, 0 strong sell). Average 12-month price target: 122.93 USD.